September 20, 2024 by King’s College London Credit: Pixabay/CC0 Public DomainA new type of blood test using lipids could make it easier to identify children at risk of complications around obesity including type two diabetes, liver and heart disease, say scientists. A new study from King’s College London published in Nature Medicine reveals a new...
September 20, 2024 by Yale University Genetic correlations among anxiety phenotypes assessed in EUR participants. Credit: Nature Genetics (2024). DOI: 10.1038/s41588-024-01908-2Investigators from the Yale Department of Psychiatry investigated the genetic profiles of more than 1 million participants enrolled in multiple cohorts around the world. Leveraging this large dataset, they uncovered more than 100 genes associated...
September 19, 2024 by European Committee for Treatment and Research in Multiple Sclerosis Credit: Pixabay/CC0 Public DomainA study presented at ECTRIMS 2024 has identified critical biomarkers that can predict disability worsening in multiple sclerosis (MS). The breakthrough research has the potential to transform treatment strategies for millions of MS patients worldwide, paving the way for...
September 18, 2024 NIH-supported clinical trial is the first positive trial for treatment of hereditary hemorrhagic telangiectasia. A clinical trial supported by the National Institutes of Health (NIH) was stopped early after researchers found sufficient evidence that a drug used to treat bone marrow cancer and Kaposi sarcoma is safe and effective in treating hereditary...
MigraineA meta-analysis of 137 trials of migraine drugs indicates that the newest class of treatments are less effective than the previous generation of triptan drugs in relieving acute headaches. A study from The BMJ indicates that the newest class of migraine drugs—which includes Pfizer’s Nurtec, AbbVie’s Ubrelvy and Eli Lilly’s Reyvow—is less effective in the...
